Preliminary research turns to a fully implantable system ...
“Surgical therapy for diabetic gastroparesis is associated with improved glycemic control and reduced diabetes-related ...
Renexxion plans to file new drug application (NDA) with the Food and Drug Administration (FDA) using future Phase 3 results ROSCREA, Ireland and ...
MS symptoms can include fatigue, muscle weakness, vision issues, cognitive dysfunction, and more. Early symptoms of MS often include eye pain, blurred vision, numbness, or tingling in the arms and ...
At a median 5-year (60.3 months) planned follow-up of the Phase 2b KEYNOTE-942/mRNA-4157-P201 study, intismeran autogene in combination with KEYTRUDA demonstrated a 49% reduction in the risk of ...
Department of Molecular Neuroscience and Reta Lila Weston Institute of Neurological Studies, Institute of Neurology, University College London and the National Hospital for Neurology and Neurosurgery, ...